Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
TNFRSF1B Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
TNFRSF1B target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
TNFRSF1A Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
TNFRSF1A target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
TNF Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
TNF target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
IL1R1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
IL1R1 target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
IL1B Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
IL1B target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
IL6 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
IL6 target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
IL6R Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
IL6R target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
TYK2 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
TYK2 target evaluation report generated from PatSnap MCP data, assessing interferon/interleukin signaling biology, clinical evidence, competition, IP, and R&D strategy.
Latest Hotspot
8 min read
JAK3 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
JAK3 target evaluation report from PatSnap MCP data, evaluating common gamma-chain cytokine signaling, validation evidence, competition, IP, and R&D strategy.
Latest Hotspot
8 min read
JAK1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
JAK1 target evaluation report generated with PatSnap MCP data, covering cytokine signaling biology, validation evidence, competitive landscape, IP, and R&D strategy.
Latest Hotspot
8 min read
CSF3R Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
CSF3R target evaluation report built from PatSnap MCP data, assessing G-CSF receptor biology, clinical validation, competition, IP, and R&D strategy.
Latest Hotspot
8 min read
PDGFRB Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
PDGFRB target evaluation report generated from PatSnap MCP data, covering PDGFR beta biology, clinical evidence, competition, IP, and R&D strategy.